MentalHealthDaily

Ketamine Increases Amygdala Volume in Treatment-Resistant Depression (TRD) (2024 MRI Study)

by GLOOM

Depression is a complex mental health condition that significantly affects an individual’s emotional and physical well-being. Recent advances in neuroimaging have provided deeper insights into how major depressive disorder (MDD) alters brain structures, particularly the hippocampus and amygdala, and how treatments like ketamine can potentially reverse these changes. A new study using 3T and 7T …

Nortriptyline-Induced “Room Tilt Illusion”: A Rare Adverse Event of Antidepressants (2024 Case Report)

by GLOOM

Room Tilt Illusion (RTI) presents a perplexing challenge to both patients and physicians, transforming the familiar into the surreal as surroundings appear rotated or flipped. This rare condition, often linked to neurological or vestibular disorders, has recently been observed as an adverse effect of the antidepressant nortriptyline, used in treatment-resistant depression. A case report highlights …

Empagliflozin for Depression: Effective Adjunct with SSRIs (2024 Clinical Trial)

by GLOOM

Major Depressive Disorder (MDD) impacts millions globally, making it a significant public health challenge. Traditional treatments like Selective Serotonin Reuptake Inhibitors (SSRIs) don’t work for everyone, highlighting the need for innovative approaches. Recent clinical trials exploring the use of empagliflozin, a medication originally used to lower blood sugar in diabetes patients, have shown promising results …

EPA & DHA Treat Depression in Mouse Models of Ulcerative Colitis (UC) (2024 Study)

by GLOOM

Recent research has uncovered significant insights into the intersection of physical and mental health, particularly focusing on the relationship between ulcerative colitis (UC) and depression. This study has delved into how two omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), can alleviate depressive-like behavior in mice induced by UC. Through meticulous experimentation, it …

Black Seed Oil (Nigella Sativa) Effectively Reverses Antibiotic-Induced Depression in Mice (2024 Study)

by GLOOM

In a world increasingly reliant on antibiotics, emerging research sheds light on the unintended consequences of their chronic use, revealing significant impairments in mitochondrial function, hypothalamus-mediated metabolic operations, and amygdala-regulated emotional processes. A novel study has explored the potential of black seed oil (Nigella sativa oil, NSO) to mitigate these adverse effects, focusing on its …

Xylopic Acid for Depression: May Increase Efficacy of Select Antidepressants via Synergistic Effect (2024 Study)

by GLOOM

In a new study, researchers discovered the synergistic antidepressant-like effects of xylopic acid (XA), a natural compound extracted from the dried fruits of Xylopia aethiopica, when combined with conventional antidepressants in mice. The study meticulously explored the interaction between XA and antidepressants like fluoxetine, sertraline, imipramine, and ketamine, revealing a promising potential for enhancing antidepressant …

Abnormal Brain EEG Activity Doesn’t Predict Antidepressant Efficacy in Depression (2023 Study)

by GLOOM

Depression is a multifaceted mental health condition that presents significant challenges in both diagnosis and treatment. Recent studies have explored the potential of electroencephalography (EEG) as a predictive tool for treatment outcomes in major depressive disorder (MDD), with particular focus on the response to antidepressants like escitalopram. Highlights: EEG Abnormalities & Antidepressant Response: Contrary to …